Following the programs success, tirzepatide was approved by the United States Food and Drug Administration (FDA) in 2022 as a treatment for T2D, at doses up to 15mg/weekly under the brand name Mounjaro [1, 5]
"Distribution and characterisation of Glucagon-like peptide-1 receptor expressing cells in the mouse brain"
Localized education, safety messaging and clear referral routes can help patients follow treatment requirements correctly
The Laboratory shall not provide results, documentation or advice that, in any way, suggests endorsement of products or services
Take control of your metabolic health without the stress or intensity of standard GLP-1 therapy
CrossRef XBP1s-Regulated GFPT1 via Facilitating O-GlcNAcylation of FASN S509 Is Involved in Arsenic-Induced MASLD through Promoting Fatty Acid Synthesis in Hepatocytes Wenjie Li, Bowen Fan, Han Li, Qiong Du, Jiaheng Lin, Yi Yang, Xiaolin Ding, Haoran Zhang, Haibo Xia, Binafsha Manzoor Syed, Cheng Cheng, Qizhan Liu Journal of Agricultural and Food Chemistry .2026
